Rights and permissions
About this article
Cite this article
Eptifibatide cost-effective option for coronary interventions. Pharmacoecon. Outcomes News 335, 9 (2001). https://doi.org/10.1007/BF03280581
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03280581